Previous 10 | Next 10 |
Stealth BioTherapeutics (MITO) +31% on Q1 results.Ultralife Corporation (ULBI) +22% on new contract from U.S. Army.China HGS Real Estate Inc. (HGSH) +14% on Q2 results.XpresSpa Group (XSPA) +9% on Q1 results.Reliance Global Group (RELI) +8%.Express (EXPR) +7%.Eloxx Pharmac...
The independent Data Safety Monitoring Board ((DSMB)) has unanimously recommended to continue the study of RedHill Biopharma's (RDHL) Phase 2/3 study with orally-administered opaganib (Yeliva, ABC294640) in patients hospitalized with severe COVID-19, following a fourth safety review.The recom...
RedHill Biopharma's Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue Independent Data Safety Monitoring Board unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib in severe COVID...
Universe Pharmaceuticals (UPC) +113%.Humanigen (HGEN) +61% on positive Phase 3 data for COVID-19 therapy.Cyanotech Corporation (CYAN) +48%.Big Rock Partners Acquisition (BRPA) +42%.SeaChange International (SEAC) +34% on multi-million-dollar contract with broadband service provider.F...
The pandemic has cut into RedHill's growing potential. RedHill should exit the pandemic with new growth drivers ready to rumble. RedHill has two serious COVID-19 therapies which it is advancing in late stage clinical trials. RedHill has a late stage pipeline with several promi...
RedHill Biopharma ([[RDHL]]), AztraZeneca AB, AstraZenca Pharmaceuticals and Nektar Therapeutics have entered into a settlement and license agreement with MSN Pharmaceuticals and MSN Laboratories resolving their patent litigation in the U.S. in response to MSN's FDA Abbreviated...
RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with MSN Pharmaceuticals PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , March 25, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a speci...
RedHill Biopharma Announces Compassionate Use Treatment with Opaganib of first COVID-19 Patients in Switzerland PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , March 22, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Compan...
RedHill Biopharma Ltd. (RDHL) Q4 2020 Earnings Conference Call Mar 18, 2021, 08:30 AM ET Company Participants Alexandra Okmian - Senior Business Development and Investor Relations Manager Dror Ben-Asher - CEO Micha Chorin - CFO Rick Scruggs - Chief Commercial Officer Gilead Raday - COO Guy Go...
RedHill (RDHL): FY net loss of $76M.Revenue of $64.3M (+922.3% Y/Y) misses by $3.83M.Press Release For further details see: RedHill misses on revenue
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd. Company Name:
RDHL Stock Symbol:
NASDAQ Market:
Redhill Biopharma Ltd. Website:
RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien PR Newswire TEL-AVIV, Israel and RALEIGH, NC , July 22, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biophar...
RedHill Biopharma Terminates License Agreement for Aemcolo® PR Newswire TEL-AVIV, Israel and RALEIGH, NC , July 9, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today ...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...